Resultados da pesquisa - Kristina S. Boye

EQ-5D: a plea for accurate nomenclature Por Richard Brooks, Kristina S. Boye, Bernhard Slaap

Connect to this object online.

Development of a patient-reported outcome (PRO) measure to assess patient perceptions of simplicity and complexity of treatment for type 2 diabetes Por Katie D. Stewart, Louis S. Matza, Hiren Patel, Kristina S. Boye

Connect to this object online.

Validity and analysis of the Diabetes Injection Device Preference Questionnaire (DID-PQ) Por Kristina S. Boye, Louis S. Matza, Brooke M. Currie, Karin S. Coyne

Connect to this object online.

Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes Por Louis S. Matza, Kristina S. Boye, Katie D. Stewart, Evan W. Davies, Rosirene Paczkowski

Connect to this object online.

Development of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ) Por Louis S. Matza, Kristina S. Boye, Katie D. Stewart, Rosirene Paczkowski, Jessica Jordan, Lindsey T. Murray

Connect to this object online.

Psychometric evaluation of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ) Por Louis S. Matza, Katie D. Stewart, Rosirene Paczkowski, Karin S. Coyne, Brooke Currie, Kristina S. Boye

Connect to this object online.

Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK Por Kristina S. Boye, Dara Stein, Louis S. Matza, Jessica Jordan, Ren Yu, Kirsi Norrbacka, Syed Wasi Hassan, Luis-Emilio

Connect to this object online.